JERUSALEM, August 29, 2017 /PRNewswire/ —
Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming Rodman & Renshaw 19th Annual Global Investment Conference, taking place on September 10-12, 2017 in New York City. Nadav Kidron, Oramed’s CEO, will present a corporate overview at the conference on September 12, 2017.
Rodman & Renshaw 19th Annual Global Investment Conference
Date: Tuesday, September 12, 2017
Time: 1:45 p.m. EST
Location: The Lotte New York Palace Hotel, New York (Kennedy II Room)
About Oramed Pharmaceuticals
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed’s Protein Oral Delivery (POD